Tags

Type your tag names separated by a space and hit enter

Human schistosomiasis.
Lancet. 2006 Sep 23; 368(9541):1106-18.Lct

Abstract

Schistosomiasis or bilharzia is a tropical disease caused by worms of the genus Schistosoma. The transmission cycle requires contamination of surface water by excreta, specific freshwater snails as intermediate hosts, and human water contact. The main disease-causing species are S haematobium, S mansoni, and S japonicum. According to WHO, 200 million people are infected worldwide, leading to the loss of 1.53 million disability-adjusted life years, although these figures need revision. Schistosomiasis is characterised by focal epidemiology and overdispersed population distribution, with higher infection rates in children than in adults. Complex immune mechanisms lead to the slow acquisition of immune resistance, though innate factors also play a part. Acute schistosomiasis, a feverish syndrome, is mostly seen in travellers after primary infection. Chronic schistosomal disease affects mainly individuals with long-standing infections in poor rural areas. Immunopathological reactions against schistosome eggs trapped in the tissues lead to inflammatory and obstructive disease in the urinary system (S haematobium) or intestinal disease, hepatosplenic inflammation, and liver fibrosis (S mansoni, S japonicum). The diagnostic standard is microscopic demonstration of eggs in the excreta. Praziquantel is the drug treatment of choice. Vaccines are not yet available. Great advances have been made in the control of the disease through population-based chemotherapy but these required political commitment and strong health systems.

Authors+Show Affiliations

Institute for Tropical Medicine Antwerp, Nationalestraat 155 B-2000, Antwerp, Belgium. bgryseels@itg.beNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't
Review

Language

eng

PubMed ID

16997665

Citation

Gryseels, Bruno, et al. "Human Schistosomiasis." Lancet (London, England), vol. 368, no. 9541, 2006, pp. 1106-18.
Gryseels B, Polman K, Clerinx J, et al. Human schistosomiasis. Lancet. 2006;368(9541):1106-18.
Gryseels, B., Polman, K., Clerinx, J., & Kestens, L. (2006). Human schistosomiasis. Lancet (London, England), 368(9541), 1106-18.
Gryseels B, et al. Human Schistosomiasis. Lancet. 2006 Sep 23;368(9541):1106-18. PubMed PMID: 16997665.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Human schistosomiasis. AU - Gryseels,Bruno, AU - Polman,Katja, AU - Clerinx,Jan, AU - Kestens,Luc, PY - 2006/9/26/pubmed PY - 2006/9/29/medline PY - 2006/9/26/entrez SP - 1106 EP - 18 JF - Lancet (London, England) JO - Lancet VL - 368 IS - 9541 N2 - Schistosomiasis or bilharzia is a tropical disease caused by worms of the genus Schistosoma. The transmission cycle requires contamination of surface water by excreta, specific freshwater snails as intermediate hosts, and human water contact. The main disease-causing species are S haematobium, S mansoni, and S japonicum. According to WHO, 200 million people are infected worldwide, leading to the loss of 1.53 million disability-adjusted life years, although these figures need revision. Schistosomiasis is characterised by focal epidemiology and overdispersed population distribution, with higher infection rates in children than in adults. Complex immune mechanisms lead to the slow acquisition of immune resistance, though innate factors also play a part. Acute schistosomiasis, a feverish syndrome, is mostly seen in travellers after primary infection. Chronic schistosomal disease affects mainly individuals with long-standing infections in poor rural areas. Immunopathological reactions against schistosome eggs trapped in the tissues lead to inflammatory and obstructive disease in the urinary system (S haematobium) or intestinal disease, hepatosplenic inflammation, and liver fibrosis (S mansoni, S japonicum). The diagnostic standard is microscopic demonstration of eggs in the excreta. Praziquantel is the drug treatment of choice. Vaccines are not yet available. Great advances have been made in the control of the disease through population-based chemotherapy but these required political commitment and strong health systems. SN - 1474-547X UR - https://www.unboundmedicine.com/medline/citation/16997665/Human_schistosomiasis_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0140-6736(06)69440-3 DB - PRIME DP - Unbound Medicine ER -